Drugs / mRNA-1608
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06033261 | Sep 2023 → Apr 2025 | genital herpes | ModernaTX, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-1608 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06033261 ↗ |
| Route | Intramuscular | “2 intramuscular (IM) injections of mRNA-1608” NCT06033261 ↗ |